First Time Loading...

TherapeuticsMD Inc
NASDAQ:TXMD

Watchlist Manager
TherapeuticsMD Inc Logo
TherapeuticsMD Inc
NASDAQ:TXMD
Watchlist
Price: 1.86 USD -0.53% Market Closed
Updated: Apr 27, 2024

Intrinsic Value

TXMD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

TherapeuticsMD, Inc. operates as a pharmaceutical company. [ Read More ]

The intrinsic value of one TXMD stock under the Base Case scenario is 2.45 USD. Compared to the current market price of 1.86 USD, TherapeuticsMD Inc is Undervalued by 24%.

Key Points:
TXMD Intrinsic Value
Base Case
2.45 USD
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
TherapeuticsMD Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TXMD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
TherapeuticsMD Inc

Provide an overview of the primary business activities
of TherapeuticsMD Inc.

What unique competitive advantages
does TherapeuticsMD Inc hold over its rivals?

What risks and challenges
does TherapeuticsMD Inc face in the near future?

Has there been any significant insider trading activity
in TherapeuticsMD Inc recently?

Summarize the latest earnings call
of TherapeuticsMD Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for TherapeuticsMD Inc.

Provide P/S
for TherapeuticsMD Inc.

Provide P/E
for TherapeuticsMD Inc.

Provide P/OCF
for TherapeuticsMD Inc.

Provide P/FCFE
for TherapeuticsMD Inc.

Provide P/B
for TherapeuticsMD Inc.

Provide EV/S
for TherapeuticsMD Inc.

Provide EV/GP
for TherapeuticsMD Inc.

Provide EV/EBITDA
for TherapeuticsMD Inc.

Provide EV/EBIT
for TherapeuticsMD Inc.

Provide EV/OCF
for TherapeuticsMD Inc.

Provide EV/FCFF
for TherapeuticsMD Inc.

Provide EV/IC
for TherapeuticsMD Inc.

Show me price targets
for TherapeuticsMD Inc made by professional analysts.

What are the Revenue projections
for TherapeuticsMD Inc?

How accurate were the past Revenue estimates
for TherapeuticsMD Inc?

What are the Net Income projections
for TherapeuticsMD Inc?

How accurate were the past Net Income estimates
for TherapeuticsMD Inc?

What are the EPS projections
for TherapeuticsMD Inc?

How accurate were the past EPS estimates
for TherapeuticsMD Inc?

What are the EBIT projections
for TherapeuticsMD Inc?

How accurate were the past EBIT estimates
for TherapeuticsMD Inc?

Compare the revenue forecasts
for TherapeuticsMD Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of TherapeuticsMD Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of TherapeuticsMD Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of TherapeuticsMD Inc compared to its peers.

Compare the P/E ratios
of TherapeuticsMD Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing TherapeuticsMD Inc with its peers.

Analyze the financial leverage
of TherapeuticsMD Inc compared to its main competitors.

Show all profitability ratios
for TherapeuticsMD Inc.

Provide ROE
for TherapeuticsMD Inc.

Provide ROA
for TherapeuticsMD Inc.

Provide ROIC
for TherapeuticsMD Inc.

Provide ROCE
for TherapeuticsMD Inc.

Provide Gross Margin
for TherapeuticsMD Inc.

Provide Operating Margin
for TherapeuticsMD Inc.

Provide Net Margin
for TherapeuticsMD Inc.

Provide FCF Margin
for TherapeuticsMD Inc.

Show all solvency ratios
for TherapeuticsMD Inc.

Provide D/E Ratio
for TherapeuticsMD Inc.

Provide D/A Ratio
for TherapeuticsMD Inc.

Provide Interest Coverage Ratio
for TherapeuticsMD Inc.

Provide Altman Z-Score Ratio
for TherapeuticsMD Inc.

Provide Quick Ratio
for TherapeuticsMD Inc.

Provide Current Ratio
for TherapeuticsMD Inc.

Provide Cash Ratio
for TherapeuticsMD Inc.

What is the historical Revenue growth
over the last 5 years for TherapeuticsMD Inc?

What is the historical Net Income growth
over the last 5 years for TherapeuticsMD Inc?

What is the current Free Cash Flow
of TherapeuticsMD Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for TherapeuticsMD Inc.

Financials

Balance Sheet Decomposition
TherapeuticsMD Inc

Current Assets 11.8m
Cash & Short-Term Investments 4.3m
Receivables 3.1m
Other Current Assets 4.4m
Non-Current Assets 31.5m
PP&E 6.9m
Intangibles 6.1m
Other Non-Current Assets 18.5m
Current Liabilities 6.9m
Accounts Payable 27k
Accrued Liabilities 2.7m
Other Current Liabilities 4.1m
Non-Current Liabilities 7.2m
Other Non-Current Liabilities 7.2m
Efficiency

Earnings Waterfall
TherapeuticsMD Inc

Revenue
1.3m USD
Cost of Revenue
0 USD
Gross Profit
1.3m USD
Operating Expenses
-9.8m USD
Operating Income
-8.5m USD
Other Expenses
-1.8m USD
Net Income
-10.3m USD

Free Cash Flow Analysis
TherapeuticsMD Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

TXMD Profitability Score
Profitability Due Diligence

TherapeuticsMD Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Negative Operating Income
Negative Net Income
43/100
Profitability
Score

TherapeuticsMD Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

TXMD Solvency Score
Solvency Due Diligence

TherapeuticsMD Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

TherapeuticsMD Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TXMD Price Targets Summary
TherapeuticsMD Inc

Wall Street analysts forecast TXMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TXMD is 5 USD .

Lowest
Price Target
Not Available
Average
Price Target
5 USD
169% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

TXMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

TXMD Price
TherapeuticsMD Inc

1M 1M
-17%
6M 6M
-7%
1Y 1Y
-49%
3Y 3Y
-97%
5Y 5Y
-99%
10Y 10Y
-99%
Annual Price Range
1.86
52w Low
1.86
52w High
4.49
Price Metrics
Average Annual Return -57.17%
Standard Deviation of Annual Returns 13.04%
Max Drawdown -99%
Shares Statistics
Market Capitalization 21.4m USD
Shares Outstanding 10 575 200
Percentage of Shares Shorted 0.47%

TXMD Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

TherapeuticsMD Inc Logo
TherapeuticsMD Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

21.4m USD

Dividend Yield

0%

Description

TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 416 full-time employees. The company went IPO on 2001-01-31. Its contraceptive products include ANNOVERA. ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its prenatal vitamin products include vitaTrue, vitaPearl, and BocaGreenMD Prena1 True.

Contact

FLORIDA
Boca Raton
951 W Yamato Rd Ste 220
+15619611900.0
https://www.therapeuticsmd.com/

IPO

2001-01-31

Employees

416

Officers

Executive Chairman
Governor Thomas G. Thompson
Chief Executive Officer
Mr. Marlan D. Walker J.D.
Co-Founder
Mr. Robert G. Finizio
Interim CFO & Chief Accounting Officer
Mr. Michael C. Donegan
Chief Compliance Officer
Ms. Daniella Silva
Vice President of Human Resources
Mr. Benjamin Foulk
Show More
Chief Manufacturing Officer
Mr. Bharat Warrier
Vice President of Market Access
Mr. Douglas Steelman
Vice President of Strategic Partnerships & Initiatives
Ms. Dedra Lyden
Show Less

See Also

Discover More
What is the Intrinsic Value of one TXMD stock?

The intrinsic value of one TXMD stock under the Base Case scenario is 2.45 USD.

Is TXMD stock undervalued or overvalued?

Compared to the current market price of 1.86 USD, TherapeuticsMD Inc is Undervalued by 24%.